CK Life’s new CEO counts on Big Pharma experience to boost new drug success, earnings

SCMP | Oct. 8, 2024, 7:13 a.m. | Original
Lance Yuen spent two decades at Bristol-Myers Squibb and Bayer in the region before becoming the CEO at CK Life Sciences last month.
Huge potential for jobs in China after stimulus measures, national planners say 10 years after Flint water crisis, Biden sets deadline for US cities to replace lead pipes